ALL06 A Phase II trial of an intensive pediatric protocol incorporating post-induction stratification based on minimal residual disease levels for the treatment of adolescents aged 15 years and above, and young adults aged up to 40 years, with newly diagnosed acute lymphoblastic leukaemia (ALL)

Name: ALL06 A Phase II trial of an intensive pediatric protocol incorporating post-induction stratification based on minimal residual disease levels for the treatment of adolescents aged 15 years and above, and young adults aged up to 40 years, with newly diagnosed acute lymphoblastic leukaemia (ALL)
Creator: Health Data Australia Contributor Records
Published: 2024-08-03T10:25:18+08:00

Research Data Australia2024-08-03 收录

临床试验

白血病治疗

数据链接：

https://researchdata.edu.au/all06-a-phase-leukaemia-all/2538342 数据链接链接失效反馈

官方服务：

资源简介：

Dataset includes: Data for 86 patients aged 15-40 years with newly diagnosed Acute Lymphoblastic Leukaemia. Modified form of BRM-2000 protocol in the 15-40 age group. Complete remission, disease-free survival and overall survival. Toxicity

提供机构：

Health Data Australia Contributor Records

ALL06 A Phase II trial of an intensive pediatric protocol incorporating post-induction stratification based on minimal residual disease levels for the treatment of adolescents aged 15 years and above, and young adults aged up to 40 years, with newly diagnosed acute lymphoblastic leukaemia (ALL)

资源简介：

相关数据集